1. EMCDDA, European Database for New Drugs (EDND), (2021). https://ednd2.emcdda.europa.eu (accessed April 10, 2021).
2. EMCDDA, European Drug Report 2020, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal, 2020. https://www.emcdda.europa.eu/system/files/publications/13236/TDAT20001ENN_web.pdf (accessed September 28, 2020).
3. Bundesgesetzblatt [2019] Teil I: Nr. 27: S.1083, Verordn. Zur Änd. Anl. Neue-Psychoaktive-Stoffe-Gesetzes Von Anlagen Betäubungsmittelgesetzes. (2019). https://www.bgbl.de/xaver/bgbl/media/AABB2A69798E72BC2B37B4AB42FB254D/bgbl119s1083_77679.pdf (accessed September 25, 2020).
4. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE;Angerer;Drug Test. Anal.,2018
5. In vitro activity profiling of Cumyl-PEGACLONE variants at the CB 1 receptor: Fluorination versus isomer exploration;Janssens;Drug Test. Anal.,2020